Jagsonpal Pharmaceuticals

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue58.0162.1560.1049.7545.98
Expenses50.6952.0650.1444.4841.44
EBITDA8.0010.6310.645.925.15
EBIT7.5210.2410.185.514.76
Profit Before Tax7.3210.099.965.284.54
Net Profit5.607.487.473.963.55
Financial Ratios
Operating Profit Margin14.43%17.67%18.40%12.53%11.86%
Net Profit Margin10.10%12.44%12.92%8.38%8.16%
Earning Per Share (Diluted)2.142.852.841.471.31
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ